Viewing Study NCT01004250


Ignite Creation Date: 2025-12-24 @ 4:46 PM
Ignite Modification Date: 2026-01-13 @ 6:20 PM
Study NCT ID: NCT01004250
Status: COMPLETED
Last Update Posted: 2014-05-21
First Post: 2009-10-28
Is Gene Therapy: True
Has Adverse Events: True

Brief Title: A Study of Pemetrexed and Bevacizumab for Participants With Advanced Non-Small Cell Cancer
Sponsor: Eli Lilly and Company
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Non-Small Cell Lung Cancer View
Keywords: